ENA Respiratory Advances COVID-19 Preventative Therapy through AU$32 Million Funding Round
Round jointly led by Brandon Capital and Minderoo Foundation with co-investment from Uniseed will support the clinical development of INNA-051 Company appoints President and Chief Scientific Officer of the COPD Foundation and respiratory therapy expert Ruth Tal-Singer, Ph.D., to Board of Directors Sydney, Australia, 15 June – ENA Respiratory, a biotechnology company developing a first-in-class […]